A γ-Lactam Siderophore Antibiotic Effective against Multidrug-Resistant Gram-Negative Bacilli
- J Med Chem. 2020 Jun 11;63(11):5990-6002. doi: 10.1021/acs.jmedchem.0c00255.
- 1. Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio 44106, United States.
- 2. Department of Biochemistry, Case Western Reserve University, Cleveland, Ohio 44106, United States.
- 3. Yale Center for Molecular Discovery, West Haven, Connecticut 06516, United States.
- 4. Department of Medicine, Case Western Reserve University, Cleveland, Ohio 44106, United States.
- 5. Department of Pediatrics, Rush University Medical Center, Rush Medical College, Chicago, Illinois 60612, United States.
- 6. Cook County Health and Hospital Systems, Chicago, Illinois 60612, United States.
- 7. Geriatric Research, Education and Clinical Center, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio 44106, United States.
- 8. Department of Pathology, University Hospitals Cleveland Medical Center, Division of Clinical Microbiology, Cleveland, Ohio 44106, United States.
- 9. University of North Carolina School of Medicine, Chapel Hill, North Carolina 27514, United States.
- 10. Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey 07601, United States.
- 11. Departments of Pharmacology, Molecular Biology & Microbiology, and Proteomics & Bioinformatics, Case Western Reserve University, Cleveland, Ohio 44106, United States.
- 12. CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, Ohio 44106, United States.
Treatment of multidrug-resistant Gram-negative Bacterial pathogens represents a critical clinical need. Here, we report a novel γ-lactam pyrazolidinone that targets penicillin-binding proteins (PBPs) and incorporates a siderophore moiety to facilitate uptake into the periplasm. The MIC values of γ-lactam YU253434, 1, are reported along with the finding that 1 is resistant to hydrolysis by all four classes of β-lactamases. The druglike characteristics and mouse PK data are described along with the X-ray crystal structure of 1 binding to its target PBP3.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Infection